Navigation Links
A discovery by Dr. Andre Veillette's team could impact the treatment of autoimmune diseases
Date:8/19/2010

Montreal, August 19, 2010 The internationally-renowned scientific journal Immunity, from the Cell Press group, publishes online today, and will publish in its August 27 print issue, the results of a study conducted by a team of researchers led by Dr. Andr Veillette, Director of the Molecular Oncology research unit at the Institut de recherches cliniques de Montral (IRCM). Their scientific breakthrough could have an impact on the treatment of multiple sclerosis and other autoimmune diseases, which affect tens of thousands of Canadians.

Dr. Veillette's team discovered the function of a protein located in T cells, which are immune cells known as lymphocytes that play a central role in the protection against viruses and other microbial agents. They also take part in the development of certain diseases, including diabetes and multiple sclerosis. The protein in question is the "phosphatase" PTP-PEST, an enzyme that removes phosphates from other proteins in the cell.

"By removing PTP-PEST from mouse T cells, we determined that this protein was required for repeated immune responses such as those occurring during vaccination," explains Dr. Dominique Davidson, a researcher in Dr. Veillette's laboratory and first author of the study. "More particularly, we showed that PTP-PEST controls the activity of Pyk2, a molecule that stimulates the ability of cells to interact with one another and move within the body."

The researchers showed that, through this mechanism, PTP-PEST stimulates the participation of T cells in an immune reaction. Once activated, T cells encourage other immune cells to join in an immune response, thereby explaining their pivotal role in this process. The team's results also show that the elimination of PTP-PEST in T cells can prevent certain autoimmune diseases, at least in mice. This suggests that suppressing the function of PTP-PEST through medication could be of value for the treatment of some human diseases.

"The removal of PTP-PEST can unfortunately prevent immunization and weaken the response to a vaccine," concludes Dr. Veillette. "Fortunately, it can also prevent overactive immune responses and could eventually help treat autoimmune diseases. It's like a double-edged sword."

According to the Multiple Sclerosis (MS) Society of Canada, MS is the most common neurological disease affecting young Canadians. Canada is known as having one of the highest prevalence rates of multiple sclerosis in the world, with an estimated 55,000 to 75,000 Canadians living with multiple sclerosis. The MS Society estimates that approximately 1,000 new cases of MS are diagnosed in the country each year, which means three Canadians are diagnosed with the disease every day.

This research project was funded by the Canadian Institutes of Health Research (CIHR). "This new discovery regarding the immune regulatory properties of PTP-PEST may have profound implications for the treatment of MS and other autoimmune disorders," says Dr. Judith Bray, Assistant Director of the CIHR Institute of Infection and Immunity. "Current therapies for MS that target the immune system are general and can have significant adverse side effects, so clearly more specific, targeted therapies are needed. This is one of the reasons that CIHR has heavily invested in Clinical Autoimmunity research, in an effort to understand the mechanisms that cause autoimmune disorders and develop more effective treatments for them."


'/>"/>

Contact: Julie Langelier
julie.langelier@ircm.qc.ca
514-987-5555
Institut de recherches cliniques de Montreal
Source:Eurekalert

Related medicine news :

1. Discovery may aid search for anti-aging drugs
2. Discovery Moves Use of Stone Tools Back 800,000 Years
3. New discovery brings hope to treatment of incurable blood cancer
4. Discovery Opens Door for New Options in Prevention and Treatment of Mesothelioma
5. Discovery of Napoleon Hill Book Bound to Change Fate for Millions
6. B2Discovery: Entrepreneurs and researchers join forces to conquer cancer
7. Sun-induced skin cancer: new discovery permits doctors to assess genetic risk
8. U of A discovery offers promising research for spinal-cord injury treatments
9. Discovery of Stem Cell Illuminates Human Brain Evolution, Points To Therapies
10. Gene discovery potential key to cost-competitive cellulosic ethanol
11. ACS Webinar focuses on drug discovery process for small molecule therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , ... January 21, 2017 , ... Seamild, the largest ... the futuristic vision of its owner and founder. As Oat is recognized globally as ... everybody he knows personally as he believes it is a move to sow the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... of Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual ... alumni, family, friends, and community. “Coming Home 2017” will be held on ...
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa Orthopaedics (SRO) ... located at 167 Lynch Creek Way. The Petaluma office features three comfortable patient ... and rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons Dr. ...
(Date:1/21/2017)... ... 2017 , ... The Nobel Biocare™ dental implant company is ... its creos™ line of bone regenerative products. Specifically, the Nobel Biocare™ ... creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In addition ...
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between ... they no longer use or need, from clothes to couches to dressers and bicycles. ... and take them to the nearest Goodwill donation center through February 28th. , ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Research and Markets has announced the addition of ... BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, ... 2024" report to their offering. ... The global clinical laboratory testing market is ... of innovative solutions on the grounds of maximum efficiency and minimum ...
(Date:1/20/2017)... BUFFALO, N.Y. , Jan. 20, 2017 /PRNewswire/ ... health programs, has announced the launch of an ... to new guidelines on opioids and helps stem ... Opioids are often prescribed to treat chronic non-cancer ... disease) despite serious risks and lack of evidence ...
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 /PRNewswire/ ... reach USD 233.7 billion by 2025, according to ... The market is anticipated to be predominantly driven ... companies, resulting into the large-scale production of new ... widen the influx of drugs at an unprecedented ...
Breaking Medicine Technology: